FN Fabrinet Insider Trading

Director Homa Bahrami sold 2,500 shares of Fabrinet (FN) at $711.91 for $1,779,775.00

Director Homa Bahrami sold 2,500 shares at $711.91 on 2026-05-22, reducing his stake by -13.3% to 16,233 shares post-transaction. The transaction price was near the 52-week high of $748.89, with stock currently at $703.86, down -6.0% from that 52-week peak. His prior sell at FN on 2025-12-01 saw the stock gain +20.2% over the following 90 days, indicating the previous sale was poorly timed; his cross-ticker track record shows 0 of 1 prior sells were well-timed at the 90-day mark. With FN trading at a P/E of 59.90 and posting +18.6% annual revenue growth against $1.2B in latest-quarter revenue, this sale occurs in a high-valuation, growth-oriented context where prior insider sales at this ticker preceded stock appreciation.

Director Kelly Thomas F sells 1,850 FN shares for $1,154,131.22; holds 17,181 post-transaction.

Kelly Thomas F, a director at Fabrinet, executed four separate sales on 2026-02-25 totaling 1,850 shares for $1,154,131.22 at a blended average price of $623.85, reducing his stake to 17,181 shares (−9.7% vs pre-transaction holdings). The timing is notable: the sales occurred well above the current price of $545.63 (the sale prices ranged from $622.47 to $625.52, compared to the 52-week high of $615.99). His prior sales at Fabrinet show a pattern of 0 of 4 trades being well-timed at the 90-day mark, with subsequent 90-day returns averaging +9.1%, indicating his prior exits were poorly positioned relative to forward stock performance. The company is trading at a P/E of 51.87 with strong revenue growth of +18.6% year-over-year, though the current stock price sits 11.4% below the 52-week high, suggesting the director is selling into a relatively high-valuation environment after a recent pull-back from peaks.

Director Kelly Thomas F sold 2,200 shares of Fabrinet (FN) at $464.14, reducing holdings to 18,764 shares

Director Kelly Thomas F sold 2,200 shares (2.2K shares) at $464.14 on 2025-12-04 for $1,021,112.40, a 10.5% reduction of his 20,964-share position. At his prior five trades at Fabrinet, all executed on 2024-03-07, he generated negative 30-day returns (ranging from -15.1% to -17.1%) but positive 90-day returns (+7.4% to +10.0%), indicating the stock recovered after those sales—a pattern of poorly-timed exits in the 90-day window (0 of 5 well-timed). The current stock price of $478.45 is only 1.7% below the 52-week high of $486.91, suggesting limited downside cushion despite strong fundamentals: FN is growing annual revenue by 18.6% and trades at a P/E of 48.82 on a market cap of $17.1B. The discretionary nature of this open-market sale, without any signal of operational distress or strategic repositioning, combined with his prior pattern of selling near peaks only to see recovery, merits continued observation but does not indicate a critical concern at this transaction size.

Director Bahrami Homa sold 3.5K FN shares at $453.75; holding down 16.0% to 18.3K shares post-sale.

Director Bahrami Homa executed a sale of 3,500 shares at $453.75 on 2025-12-01, reducing her stake from 21,816 shares to 18,316 shares—a 16.0% reduction in her holdings. The transaction was executed at a price 7.7% below the 52-week high of $486.91, while the stock has appreciated 33.9% over the past 90 days and 2.0% over the past 30 days. Fabrinet's fundamentals remain strong, with FY revenue growth of +18.6%, a P/E of 45.88, and net income of $95,926,000 in the latest quarter. The sale, valued at $1,588,114.50, represents a discretionary disposition of a significant portion of her holdings at a price that sits between current levels and prior peaks.

CEO Seamus sells 22,451 shares of FN for $10,034,497.19 on 2025-11-26, reducing stake by 48.8%.

Grady Seamus, CEO of Fabrinet, executed 4 separate sales totaling 22,451 shares for $10,034,497.19 at prices ranging from $445.38 to $448.36 on 2025-11-26, reducing his holdings from 46,024 to 23,573 shares (a 48.8% reduction). The blended average sale price was $446.95, approximately 0.6% below the current price of $449.59. At Fabrinet specifically, Seamus's prior 5 sales all occurred on 2025-08-27; all five showed positive 90-day returns (+29.0% to +31.0%), indicating none were well-timed entries (stock continued rising after those sales). The current filing occurs near the 52-week high of $486.91 (only 7.7% below it) and follows strong recent momentum: +2.0% over 30 days and +33.9% over 90 days. Cross-ticker, Seamus's 7 prior open-market sales averaged +19.8% return over 90 days, with only 14.29% well-timed rate. The significance of this sale lies in both its magnitude—nearly half his position in a $16.1B market cap company—and the timing context: executed near historical highs after sustained appreciation, though the lack of supporting documentation about motivations prevents definitive characterization of strategic intent.

FN President & COO Harpal sold 14,203 shares (50.4% of holdings) for $5.0M at $355.15 on 2025-09-04

Gill Harpal, President & COO of Fabrinet, executed a substantial sale of 14,203 shares on 2025-09-04, reducing his holdings by 50.4% from 28,186 shares to 13,983 shares at $355.15 per share. The sale was completed at a price only 0.0% below the 52-week high of $362.16, indicating execution near peak valuation. His prior trades at Fabrinet have not demonstrated favorable timing: his 2 prior same-ticker sells saw the stock rise by 22.8% and 39.9% over the 90-day periods following those transactions, meaning he sold ahead of gains rather than declines. The current valuation context shows the stock trading at a P/E of 35.68 with 18.6% annual revenue growth, and the sale occurred after a notable 54.1% run-up over 90 days and 10.4% over 30 days.

EVP Archer sells 3,333 shares at $354.48 blended; stock at 52-week high; 90d timing record poor (0/3 well-timed).

Archer Edward T., EVP of Sales & Marketing, completed 3 separate sales on 2025-09-04 totaling 3,333 shares for $1,181,473.34, reducing his holdings from 9,977 shares to 6,644 shares (-33.4%). The transactions occurred at a blended average price of $354.48, compared to a current price of $362.16, placing the stock at its 52-week high. His prior trades at Fabrinet show a poor timing record: of the 3 measurable sales since 2024-09-05, none were well-timed at the 90-day mark, with all prior sales followed by positive stock performance (90-day returns +9.9%, +8.6%, +9.6%), indicating the insider sold before subsequent rallies. The 30-day return after the 2024-09-05 sales was similarly positive (+10.4%, +9.1%, +10.1%), suggesting a pattern of selling ahead of near-term strength rather than ahead of declines. Context: FN trades at a P/E of 35.68 with annual revenue growth of +18.6%, and the current stock price is up 10.4% over 30 days and +54.1% over 90 days.

Director Olson Rollance E. sells 9,000 shares at blended avg $334.12, reducing FN stake by 38.8% to 14,201 shares

Olson Rollance E. (Director) executed 2 separate sales totaling 9,000 shares for $3,007,100.40 on 2025-09-02, reducing his holdings from 23,201 to 14,201 shares (a 38.8% reduction). The sales occurred at a blended average price of $334.12, just 3.2% below the current price of $337.53 and approximately 5.9% below the 52-week high of $355.05. His prior sales at Fabrinet across 3 separate 2024 trades showed mixed timing outcomes: the 90-day returns after those sells ranged from +7.2% to +9.6%, with a timing pattern of 0 of 3 being well-timed (meaning the stock continued rising after each sale). This current sale occurs amid strong recent momentum—the stock is up 42.3% over the past 90 days—which may reflect portfolio rebalancing rather than a downside conviction signal based on the insider's historical execution at this ticker.

EVP Archer sells 3,200 FN shares for $1.1M at $335.13, reduces stake 24.3%; prior sells consistently profitable within 90d.

Edward T. Archer, EVP of Sales & Marketing, executed two separate sales totaling 3,200 shares for $1,072,431.80, reducing his holdings from 13,177 to 9,977 shares. The blended transaction price of $335.13 is near the current price of $335.70 and within 5.4% of the 52-week high of $355.05. Reviewing his prior transaction history at Fabrinet specifically, across 5 prior sales all executed on 2023-08-29 and 2024-09-05, the average 90-day return was positive (ranging from +3.9% to +10.9%), indicating that following his previous sells at this ticker, the stock rose rather than fell—meaning his prior exits were not well-timed on a downside basis. Against this pattern of consistently positive post-sale outcomes at this ticker, the current sale occurs after a 40.3% gain over 90 days and a 6.5% gain over 30 days, suggesting the stock has already appreciated significantly since the start of this measurement period.

CEO Grady Seamus sold 9,513 shares at $328.00–$333.12 for $3,134,730.24 on 2025-08-27; holds 46,024 shares post-sale.

Grady Seamus, Chief Executive Officer of Fabrinet, executed 5 separate sales totaling 9,513 shares for $3,134,730.24 at prices ranging from $328.00 to $333.12 on 2025-08-27. This represents a -17.1% reduction of his pre-transaction holdings from 55,537 shares to 46,024 shares. The blended average sale price of $329.52 occurs near Fabrinet's 52-week high of $355.05 (currently -6.7% below), in a period when the stock has gained 42.3% over the prior 90 days and 3.3% over the prior 30 days. Historically, Grady's two prior sells at Fabrinet have shown mixed post-transaction performance: the 2024-08-23 sale declined 14.8% by the 90-day mark (well-timed), while the 2023-08-24 sale rose 3.6% by the 90-day mark (poorly-timed). The company reported strong fundamentals with annual revenue growth of 18.6%, net income of $81,290,000.00, and a P/E of 32.64, providing no obvious operational distress signal for the sale.